Drug Type Interferons, Biosimilar |
Synonyms Ingaron |
Target |
Action stimulants |
Mechanism IFNGR stimulants(Interferon gamma receptor stimulants), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Russia (01 Jan 2011), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Chlamydia Infections | Russia | 01 Jan 2011 | |
Hepatitis B | Russia | 01 Jan 2011 | |
Hepatitis C | Russia | 01 Jan 2011 | |
Herpes Zoster | Russia | 01 Jan 2011 | |
HIV Infections | Russia | 01 Jan 2011 | |
Influenza, Human | Russia | 01 Jan 2011 | |
Neoplasms | Russia | 01 Jan 2011 | |
Prostatitis | Russia | 01 Jan 2011 | |
Pulmonary Tuberculosis | Russia | 01 Jan 2011 | |
Respiratory Distress Syndrome, Newborn | Russia | 01 Jan 2011 | |
Warts | Russia | 01 Jan 2011 |
Not Applicable | - | (hvznyjbasg) = oyrlmrwcsk zmvbqdmgek (lendlvknbm ) | Positive | 01 Jan 2008 |